Material Detail

'Immuno-Oncology @Point of Care, featuring Jeffrey S. Weber, MD, PhD as Editor-in-Chief, is a clinical support platform that provides comprehensive information on immuno-oncology and the role of immune-based medicines in treating cancer, made up of a progressive series of chapters and other learning tools. It provides multimedia offerings, contextual expansion of content developed by expert faculty, and many features to personalize learning, such as bookmarking, highlighting, note taking, and search, plus a comprehensive drug database. The program includes close examination of critical topics and issues that affect patient care, and includes chapters on: • Introduction to Immuno-Oncology • The Immune System's Role in Cancer • Immunotherapy Pathways and Mechanisms of Action • Non-Small Cell Lung Cancer: Recent Advances in Immunotherapy and Immune Biomarkers • Metastatic Melanoma: New and Emerging Immunotherapies • Renal Cell Carcinoma: Novel and Evolving Immunotherapeutic Approaches The chapters are supplemented with embedded hyperlinks to external multimedia resources such as illustrations, videos, journal articles, and other resources that enhance and clarify understanding of relevant issues. This online platform offers CME, CE, and CPE credit to oncologists, dermatologists, dermatologic oncologists, primary care providers (internists and family practice practitioners), nurses/nurse practitioners, pharmacists, physician assistants who are involved in the management of patients who can benefit from immunotherapies, including those with non-small cell lung cancer, metastatic melanoma, and renal cell carcinoma.'

This is a free app

This will delete the comment from the database. This operation is not reversible. Are you sure you want to do it?

Thank you for reporting a broken "Go to Material" link in MERLOT to help us maintain a collection of valuable learning materials.

If you feel this material is inappropriate for the MERLOT Collection, please click SEND REPORT, and the MERLOT Team will investigate. Thank you!

You are being taken to the material on another site. This will open a new window.

Do not show me this again